Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 5/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710606 | 0.92 | GRIK1 (0.40) | EPHX1GRIK1RXFP1EPHX2PLA2G2A | |
| SCHEMBL6710344 | 0.90 | EPHX1 (0.38) | EPHX1RXFP1EPHX2PLA2G2A | |
| SCHEMBL6711593 | 0.88 | RXFP1 (0.43) | GRIK1RXFP1GRM4 | |
| SCHEMBL6713555 | 0.86 | RXFP1 (0.46) | GRIK1RXFP1GRM4 | |
| SCHEMBL6711896 | 0.85 | EPHX1 (0.43) | EPHX1RXFP1EPHX2ALOX15GRM4 | |
| SCHEMBL6707744 | 0.85 | RXFP1 (0.40) | GRIK1RXFP1PLA2G2AGRM4 | |
| SCHEMBL6713186 | 0.84 | RXFP1 (0.42) | GRIK1RXFP1GRM4 | |
| SCHEMBL6709891 | 0.83 | RXFP1 (0.46) | GRIK1RXFP1GRM4 | |
| SCHEMBL6711479 | 0.82 | RXFP1 (0.41) | GRIK1RXFP1GRM4 | |
| SCHEMBL6710208 | 0.82 | RXFP1 (0.44) | GRIK1RXFP1ALOX15GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | EPHX1 1869/4885GRIK1 3885/4885RXFP1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.